Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013885
Filing Date
2023-05-11
Accepted
2023-05-11 15:15:29
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20230331_10q.htm   iXBRL 10-Q 1170298
2 EXHIBIT 10.1 ex_490141.htm EX-10.1 159305
3 EXHIBIT 31.1 CERTIFICATION OF CO-CEOS ex_490142.htm EX-31.1 15662
4 EXHIBIT 31.2 CERTIFICATION OF CFO ex_490143.htm EX-31.2 16556
5 EXHIBIT 32.1 CERTIFICATION OF CO-CEOS PURSUANT TO 18 USC ex_490144.htm EX-32.1 8551
6 EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC ex_490145.htm EX-32.2 7060
  Complete submission text file 0001437749-23-013885.txt   5953698

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20230331.xsd EX-101.SCH 48385
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20230331_cal.xml EX-101.CAL 43173
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20230331_def.xml EX-101.DEF 333431
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20230331_lab.xml EX-101.LAB 294531
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20230331_pre.xml EX-101.PRE 352385
52 EXTRACTED XBRL INSTANCE DOCUMENT inbp20230331_10q_htm.xml XML 1006701
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 23910534
SIC: 2834 Pharmaceutical Preparations